Across TCGA pan-cancer cohorts, RPS27AP16 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPS27AP16 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RPS27AP16 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS27AP16 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRC show a favorable association.
KIRP, ACC, and UCEC are the cancer types where RPS27AP16 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.